Back to search
FDAFDA · Food and drugs·Recall number D-1408-2014

Dextroamphetamine Sulfate Tablets, USP, 10 mg, 100-count bottles, Rx only, Barr Laboratories, Inc., Pomona, NY 10970, NDC 0555-0953-02.

Published July 2, 2014 · Recall initiated: May 1, 2014

Summary

FDA records drug Class II recall D-1408-2014, published July 2, 2014 and initiated May 1, 2014. Recalling firm: Teva Pharmaceuticals USA; Status: Terminated; Reported quantity: 9,882 bottles; Lot: Lot # 34013122A, Exp 11/15. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed Impurities/Degradation Specifications: this product is being recalled due to an out of specification test result for impurities during stability testing.

What to do

Voluntary: Firm initiated · Letter

Get an email if DEXTROAMPHETAMINE SULFATE has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
DEXTROAMPHETAMINE SULFATE
Manufacturer
Teva Pharmaceuticals USA
Distributor
Nationwide and Puerto Rico
Lot
Lot # 34013122A, Exp 11/15
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Dextroamphetamine Sulfate Tablets, USP, 10 mg, 100-count bottles, Rx only, Barr Laboratories, Inc., Pomona, NY 10970, NDC 0555-0953-02. recalled?

Yes. FDA published recall D-1408-2014 on July 2, 2014. Reported hazard: Failed Impurities/Degradation Specifications: this product is being recalled due to an out of specification test result for impurities during stability testing.

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: DEXTROAMPHETAMINE SULFATE.